Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
The ‘Time To Act’ data navigator – A new landmark tool in the fight against the impact of COVID-19 on cancer
The European Cancer Organisation is pleased to announce the launch of the ‘Time To Act’…
Palmitic acid promotes cancer metastasis and leaves a more aggressive “memory” in tumour cells
Ninety per cent of cancer deaths are caused by metastasis, that is to say, the…
Health services and Modern Slavery: a guide to managing risks to people
The Australian Human Rights Commission and KPMG Australia are today launching, Modern Slavery in the Health…
A rare instance when preventative screening is worth the dollar cost
David Hutton, University of Michigan Very few people know about hepatitis B, the so-called silent killer, and the billions of…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.